2.83
2.83 (0%)
As of Apr 28, 2025
Aquestive Therapeutics, Inc. [AQST]
Source:
Company Overview
Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies. We are developing pharmaceutical products to deliver complex molecules through alternative administrations to invasive and inconvenient standard of care therapies.
| Country | United States |
| Headquarters | warren, new jersey |
| Phone Number | (908) 941-1900 |
| Industry | manufacturing |
| CEO | Daniel Barber |
| Website | aquestive.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $57.6 |
| Operating Profit | $-30.8 |
| Net Income | $-44.1 |
| Net Cash | $47.7 |
Profit Ratios
| Gross Margin | $57.6 |
| Operating Margin | -53.5 |
| Profit as % of Revenues | -130.4% |
| Profit as % of Assets | -55.6% |
| Profit as % of Stockholder Equity | 73.4% |
Management Effectiveness
| Return on Equity | 73.4% |
| Return on Assets | -43.5% |
| Turnover Ratio | 72.5% |
| EBITA | $-30.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $101.4 |
| Total Liabilities | $161.6 |
| Operating Cash Flow | $-35.8 |
| Investing Cash Flow | $-0.2 |
| Financing Cash Flow | $83.6 |
